Yongchul Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yongchul Lim has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Daeho Kwon
Department of Microbiology, College of Medicine, Catholic Kwandong University, Gangneung 25601, Republic of Korea
1 shared publication - Eun Jeong Cha
Department of Preventive Medicine, College of Medicine, Korea University, Seoul, Korea
1 shared publication - Eunil Lee
Department of Preventive Medicine, College of Medicine, Korea University
1 shared publication - Eunyoung Hong
Department of Public Health, Graduate School, Korea University, Seoul, Korea
1 shared publication - Hee Cheol Kim
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
1 shared publication Ji Eun Lee
Center for Theragnosis, Biomedical Research Institute, Korea Institute for Science and Technology, Seoul, Korea
1 shared publication
Latest Publications
- 28 May 2020
- Published by Wiley in Proteomics
- Vol. 20 (15-16) , e1900367
A Comprehensive Analysis of Symmetric Arginine Dimethylation in Colorectal Cancer Tissues Using Immunoaffinity Enrichment and Mass Spectrometry
Protein arginine methyltransferase 5 (PRMT5) is a major enzyme responsible for generating monomethyl‐ and symmetric dimethyl arginine in proteins.PRMT5 function is essential for cell viability and development, and its overexpression is observed in a variety of cancers. In the present study, we found that levels of PRMT5 protein and symmetric arginine dimethylation in colorectal cancer (CRC) tissues are increased compared to those in adjacent noncancerous tissues. Using immunoaffinity enrichment of methylated peptides combined with high resolution mass spectrometry, a total of 147 symmetric dimethyl‐arginine (SDMA) sites in 94 proteins were identified, many of which were RNA binding proteins and enzymes. Quantitative analysis comparing CRC and normal tissues revealed significant increase in the symmetric dimethylation of 70 arginine sites in 46 proteins and a decrease in the symmetric modification of 4 arginine sites in 4 proteins. Among the 94 proteins identified in this study, we confirmed that KSRP is a target of PRMT5 and is highly expressed in CRC tissues compared to noncancerous tissues. This study is the first comprehensive analysis of symmetric arginine dimethylation using clinical samples and extends the number of known in vivo SDMA sites. The data obtained are available via ProteomeXchange with the identifier PXD015653. This article is protected by copyright. All rights reserved
- 28 May 2020
- Published by Wiley in Proteomics
- Vol. 20 (15-16) , e1900367
A Comprehensive Analysis of Symmetric Arginine Dimethylation in Colorectal Cancer Tissues Using Immunoaffinity Enrichment and Mass Spectrometry
Protein arginine methyltransferase 5 (PRMT5) is a major enzyme responsible for generating monomethyl‐ and symmetric dimethyl arginine in proteins.PRMT5 function is essential for cell viability and development, and its overexpression is observed in a variety of cancers. In the present study, we found that levels of PRMT5 protein and symmetric arginine dimethylation in colorectal cancer (CRC) tissues are increased compared to those in adjacent noncancerous tissues. Using immunoaffinity enrichment of methylated peptides combined with high resolution mass spectrometry, a total of 147 symmetric dimethyl‐arginine (SDMA) sites in 94 proteins were identified, many of which were RNA binding proteins and enzymes. Quantitative analysis comparing CRC and normal tissues revealed significant increase in the symmetric dimethylation of 70 arginine sites in 46 proteins and a decrease in the symmetric modification of 4 arginine sites in 4 proteins. Among the 94 proteins identified in this study, we confirmed that KSRP is a target of PRMT5 and is highly expressed in CRC tissues compared to noncancerous tissues. This study is the first comprehensive analysis of symmetric arginine dimethylation using clinical samples and extends the number of known in vivo SDMA sites. The data obtained are available via ProteomeXchange with the identifier PXD015653. This article is protected by copyright. All rights reserved
- Open Access
- 1 January 2014
- Published by XMLink in Journal of Korean Medical Science
- Vol. 29 (9) , 1188-1198
2,3,7,8-Tetrachlorodibenzo-P-Dioxin Induced Cell-Specific Drug Transporters With Acquired Cisplatin Resistance in Cisplatin Sensitive Cancer Cells
Gotovdorj T, et al. J Korean Med Sci. 2014 Sep;29(9):1188-1198. https://doi.org/10.3346/jkms.2014.29.9.1188
- 1 January 2014
- Published by XMLink in Journal of Korean Medical Science
- Vol. 29 (9) , 1188-1198
Open Access2,3,7,8-Tetrachlorodibenzo-P-Dioxin Induced Cell-Specific Drug Transporters With Acquired Cisplatin Resistance in Cisplatin Sensitive Cancer Cells
Gotovdorj T, et al. J Korean Med Sci. 2014 Sep;29(9):1188-1198. https://doi.org/10.3346/jkms.2014.29.9.1188